Table 2 Treatment details and clinical outcomes of patients
From: Pipeline versus Tubridge in the treatment of unruptured posterior circulation aneurysms
Total n = 107 | PED n = 55 | TFD n = 52 | P-value | |
|---|---|---|---|---|
Treatment strategy (n, %) | 0.504 | |||
FD along | 90 (84.1) | 45 (81.8) | 45 (86.5) | |
FD and coils | 17 (15.9) | 10 (18.2) | 7 (13.5) | |
Number of FD (n, %) | 0.753 | |||
1 | 100 (93.5) | 51 (92.7) | 49 (94.2) | |
≥ 2 | 7 (6.5) | 4 (7.3) | 3 (5.8) | |
Complication (n, %) | 0.737 | |||
Hemorrhagic | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Ischemic | 9 (8.4) | 4 (7.3) | 5 (9.6) | |
Angiographic follow-up (n, %) | 0.241 | |||
Complete occlusion | 65 (80.2) | 35 (85.4) | 30 (75.0) | |
Incomplete occlusion | 16 (19.8) | 6 (14.6) | 10 (25.0) | |
Clinical follow-up time (month, mean ± SD) | 25 ± 10.3 | 23.8 ± 12.5 | 26.4 ± 7.1 | 0.196 |
Clinical outcome (n, %) | 0.954 | |||
Favorable outcome | 103 (96.3) | 53 (96.4) | 50 (96.2) | |
Unfavorable outcome | 4 (3.7) | 2 (3.6) | 2 (3.8) |